Skip to Content

CL 403 (Nevirapine extended-release 400 mg)

Pill imprint CL 403 has been identified as Nevirapine extended-release 400 mg.

Nevirapine is used in the treatment of reduction of perinatal transmission of hiv; hiv infection and belongs to the drug class NNRTIs. There is no proven risk in humans during pregnancy. Nevirapine 400 mg is not a controlled substance under the Controlled Substance Act (CSA).

Nevirapine extended-release
Imprint:
CL 403
Strength:
400 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
NNRTIs
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Cipla USA Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide